Bimekizumab Treatment Improved Key Patient-Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain, Fatigue, and Morning Stiffness: 52-Week Results from Two Phase 3 Studies
Mease PJ, Dougados M, Dubreuil M, Magrey MN, Marzo-Ortega H, Rudwaleit M, de la Loge C, Fleurinck C, Massow U, Taieb V, Deodhar A (2023)
In: Abstract Supplement ACR Convergence 2023. Arthritis & Rheumatology, 75(Suppl. 9). Hoboken: Wiley: 996-1000.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Mease, Philip J.;
Dougados, Maxime;
Dubreuil, Maureen;
Magrey, Marina Nighat;
Marzo-Ortega, Helena;
Rudwaleit, MartinUniBi;
de la Loge, Christine;
Fleurinck, Carmen;
Massow, Ute;
Taieb, Vanessa;
Deodhar, Atul
Einrichtung
Erscheinungsjahr
2023
Titel des Konferenzbandes
Abstract Supplement ACR Convergence 2023
Serien- oder Zeitschriftentitel
Arthritis & Rheumatology
Band
75
Ausgabe
Suppl. 9
Seite(n)
996-1000
Konferenz
ACR Convergence 2023
Konferenzort
San Diego, CA
Konferenzdatum
2023-11-10 – 2023-11-15
ISSN
2326-5191
eISSN
2326-5205
Page URI
https://pub.uni-bielefeld.de/record/2993463
Zitieren
Mease PJ, Dougados M, Dubreuil M, et al. Bimekizumab Treatment Improved Key Patient-Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain, Fatigue, and Morning Stiffness: 52-Week Results from Two Phase 3 Studies. In: Abstract Supplement ACR Convergence 2023. Arthritis & Rheumatology. Vol 75. Hoboken: Wiley; 2023: 996-1000.
Mease, P. J., Dougados, M., Dubreuil, M., Magrey, M. N., Marzo-Ortega, H., Rudwaleit, M., de la Loge, C., et al. (2023). Bimekizumab Treatment Improved Key Patient-Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain, Fatigue, and Morning Stiffness: 52-Week Results from Two Phase 3 Studies. Abstract Supplement ACR Convergence 2023, Arthritis & Rheumatology, 75, 996-1000. Hoboken: Wiley. https://doi.org/10.1002/art.42700
Mease, Philip J., Dougados, Maxime, Dubreuil, Maureen, Magrey, Marina Nighat, Marzo-Ortega, Helena, Rudwaleit, Martin, de la Loge, Christine, et al. 2023. “Bimekizumab Treatment Improved Key Patient-Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain, Fatigue, and Morning Stiffness: 52-Week Results from Two Phase 3 Studies”. In Abstract Supplement ACR Convergence 2023, 75:996-1000. Arthritis & Rheumatology. Hoboken: Wiley.
Mease, P. J., Dougados, M., Dubreuil, M., Magrey, M. N., Marzo-Ortega, H., Rudwaleit, M., de la Loge, C., Fleurinck, C., Massow, U., Taieb, V., et al. (2023). “Bimekizumab Treatment Improved Key Patient-Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain, Fatigue, and Morning Stiffness: 52-Week Results from Two Phase 3 Studies” in Abstract Supplement ACR Convergence 2023 Arthritis & Rheumatology, vol. 75, (Hoboken: Wiley), 996-1000.
Mease, P.J., et al., 2023. Bimekizumab Treatment Improved Key Patient-Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain, Fatigue, and Morning Stiffness: 52-Week Results from Two Phase 3 Studies. In Abstract Supplement ACR Convergence 2023. Arthritis & Rheumatology. no.75 Hoboken: Wiley, pp. 996-1000.
P.J. Mease, et al., “Bimekizumab Treatment Improved Key Patient-Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain, Fatigue, and Morning Stiffness: 52-Week Results from Two Phase 3 Studies”, Abstract Supplement ACR Convergence 2023, Arthritis & Rheumatology, vol. 75, Hoboken: Wiley, 2023, pp.996-1000.
Mease, P.J., Dougados, M., Dubreuil, M., Magrey, M.N., Marzo-Ortega, H., Rudwaleit, M., de la Loge, C., Fleurinck, C., Massow, U., Taieb, V., Deodhar, A.: Bimekizumab Treatment Improved Key Patient-Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain, Fatigue, and Morning Stiffness: 52-Week Results from Two Phase 3 Studies. Abstract Supplement ACR Convergence 2023. Arthritis & Rheumatology. 75, p. 996-1000. Wiley, Hoboken (2023).
Mease, Philip J., Dougados, Maxime, Dubreuil, Maureen, Magrey, Marina Nighat, Marzo-Ortega, Helena, Rudwaleit, Martin, de la Loge, Christine, Fleurinck, Carmen, Massow, Ute, Taieb, Vanessa, and Deodhar, Atul. “Bimekizumab Treatment Improved Key Patient-Reported Symptoms of Axial Spondyloarthritis Including Spinal Pain, Fatigue, and Morning Stiffness: 52-Week Results from Two Phase 3 Studies”. Abstract Supplement ACR Convergence 2023. Hoboken: Wiley, 2023.Vol. 75. Arthritis & Rheumatology. 996-1000.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar